コンパニオンアニマル関節炎市場：動物タイプ別、適応症別、治療法別、流通チャネル別、地域別

コンパニオンアニマル関節炎の世界市場は、2025年には46億7,000万米ドルと推定され、2032年までには78億米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は7.6%で成長する見込みです。

図.コンパニオンアニマル関節炎市場シェア（%）、地域別（2025年）

変形性関節症（OA）は、犬や猫が罹患する一般的な疾患です。低悪性度の炎症性進行性退行性関節疾患であることが特徴です。変形性関節症は、軟骨下骨代謝の変化、骨棘、滑膜炎症に伴う関節軟骨の変性と修復異常から生じます。コンパニオンアニマルでは、関節弛緩症、骨軟骨症、外傷などのような基礎的な異常から二次的にOAが生じることがほとんどです。これは関節包の線維化や骨膜の反応を含む病理学的プロセスであり、歩行や可動域の変化につながります。その結果、筋骨格系や二次的な関節安定装置の劣化が起こり、異常な負荷や摩耗によって関節軟骨がさらに劣化します。

市場力学：

コンパニオンアニマル関節炎の世界市場は、主に新規治療薬の市場開拓の増加によって牽引されています。例えば、カナダ保健研究機構（CIHR）は、犬の変形性関節症の治療に対する間葉系幹細胞の有効性を評価することに焦点を当て、2021年に開始された60万米ドルのコンピュータ支援設計（CAD）プロジェクトに資金を提供しました。この研究では、顧客が所有する肘関節症または距骨変形性関節症の犬を対象とした無作為化二重盲検プラセボ対照臨床試験が行われます（出典：CIHRプロジェクト資金提供）。これらの研究から得られる知見は、新たな再生医療の可能性についての貴重な洞察を与えてくれると思われます。さらに、高度な治療の選択肢が増えることで、より多くの飼い主が獣医師の助けを借りてペットの関節炎を積極的に管理するようになると思われます。このことは、コンパニオンアニマル関節炎市場の予見可能な将来の継続的な拡大を促進すると考えられています。

本調査の主な特徴

• 本レポートは、コンパニオンアニマル関節炎の世界市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模および複合年間成長率（CAGR%）を提供します。
• また、異なるセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 本レポートでは、コンパニオンアニマル関節炎の世界市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
• 本レポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• コンパニオンアニマル関節炎の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、コンパニオンアニマル関節炎の世界市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 主なハイライト
• 規制シナリオ
• サービス提供ポートフォリオ
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• パイプライン分析

第4章 世界のコンパニオンアニマル関節炎市場 - コロナウイルス（COVID-19）パンデミックの影響

• COVID-19疫学
• 供給側と需要側の分析
• 経済への影響

第5章 世界のコンパニオンアニマル関節炎市場：動物タイプ別、2020年～2032年

• 犬
• 猫
• その他

第6章 世界のコンパニオンアニマル関節炎市場：適応症別、2020年～2032年

• 変形性関節症
• その他の関節炎

第7章 世界のコンパニオンアニマル関節炎市場、治療別、2020年～2032年

• 薬剤
• NSAIDs
• モノクローナル抗体
• その他医薬品
• サプリメント
• その他の治療法

第8章 世界のコンパニオンアニマル関節炎市場、流通チャネル別、2020年～2032年

• 動物病院・クリニック
• 小売薬局
• オンラインストア
• その他

第9章 世界のコンパニオンアニマル関節炎市場、地域別、2020年～2032年

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東
• アフリカ

第10章 競合情勢

• Vetoquinol
• NexGen Pharmaceuticals
• Norbrook
• Eltech K-Laser s.r.l
• Zoetis
• Virbac
• Elanco
• Boehringer Ingelheim International GmbH
• Ceva
• Dechra Pharmaceuticals PLC
• Others Prominent Players

第11章 セクション

• 調査手法
• 出版社について

Global Companion Animal Arthritis Market is estimated to be valued at USD 4.67 Bn in 2025 and is expected to reach USD 7.8 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032.

Figure. Companion Animal Arthritis Market Share (%), By Region 2025

Osteoarthritis (OA) is a common condition that affects dogs and cats. It is characterized as a low-grade inflammatory, progressive degenerative joint disease. OA results from degeneration and aberrant repair of articular cartilage in association with alterations in subchondral bone metabolism, osteophytosis, and synovial inflammation. In companion animals, OA is almost always secondary to an underlying abnormality, such as joint laxity, osteochondrosis, trauma, etc. It is a pathological process that includes joint capsule fibrosis and periosteal reactions, leading to an altered gait and range of motion. In turn, there is a deterioration of the musculoskeletal system and secondary joint stabilizers, resulting in further deterioration of articular cartilage due to abnormal loading and wear.

Market Dynamics:

The global companion animal arthritis market is mainly driven by the increasing development of novel therapeutics. For instance, the Canadian Institutes of Health Research (CIHR) funded a US$600,000 Computer-aided design (CAD) project launched in 2021 focused on evaluating the efficacy of mesenchymal stem cells for the treatment of osteoarthritis in dogs. The study involves a randomized, double-blinded, placebo-controlled clinical trial involving client-owned dogs with elbow or stifle osteoarthritis (source: CIHR project funding). Findings from these studies will provide valuable insights into the potential of new regenerative medicine options. Furthermore, the greater availability of advanced treatment choices will encourage more pet owners to actively manage their pet's arthritis with the help of veterinarians. This, in turn, will fuel ongoing expansion in the companion animal arthritis market beyond the foreseeable future.

Key features of the study:

• This report provides in-depth analysis of the global companion animal arthritis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global companion animal arthritis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Vetoquinol, NexGen Pharmaceuticals, Norbrook, Eltech K-Laser s.r.l, Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC .
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global companion animal arthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal arthritis market

Global Companion animal arthritis Market Detailed Segmentation:

• By Animal Type
  • Dogs
  • Cats
  • Others
• By Indication
  • Osteoarthritis
  • Other Arthritis
• By Treatment
  • Medication
  • NSAIDs
  • Monoclonal Antibodies
  • Others Medications
  • Supplements
  • Other Treatment
• By Distribution Channel
  • Veterinary Hospitals & Clinics
  • Retail Pharmacies
  • Online Stores
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Vetoquinol
  • NexGen Pharmaceuticals
  • Norbrook
  • Eltech K-Laser s.r.l
  • Zoetis
  • Virbac
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Dechra Pharmaceuticals PLC
  • Others Prominent Players .

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Companion Animal Arthritis Market, By Animal Type
  • Global Companion Animal Arthritis Market, By Treatment
  • Global Companion Animal Arthritis Market, By Indication
  • Global Companion Animal Arthritis Market, By Distribution Channel
  • Global Companion Animal Arthritis Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising Concerns About Self-Image and Confidence
  • Side effects of treatment options
  • Untapped emerging markets
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Pipeline Analysis

4. Global Companion Animal Arthritis Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Companion Animal Arthritis Market, By Animal Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Dogs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cats
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Companion Animal Arthritis Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Osteoarthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Companion Animal Arthritis Market, By Treatment, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• NSAIDs
• Monoclonal Antibodies
• Others Medications
• Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other Treatments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Companion Animal Arthritis Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Veterinary Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Online Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Companion Animal Arthritis Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Vetoquinol
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NexGen Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Norbrook
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Eltech K-Laser s.r.l
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Zoetis
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Virbac
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Elanco
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boehringer Ingelheim International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ceva
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Dechra Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Others Prominent Players
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us